Mga Batayang Estadistika
| CIK | 1841873 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Khosla Ventures Acquisition Co - Class A
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| February 14, 2024 |
KVSA / Khosla Ventures Acquisition Co - Class A / CITADEL ADVISORS LLC - SC 13G/A Passive Investment SC 13G/A 1 tm243302-6sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 (Amendment No. 3)* KHOSLA VENTURES ACQUISITION CO. (Name of Issuer) Class A Common Stock, par value $0.0001 per share |
|
| December 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-40131 KHOSLA VENTURES ACQUISITION CO. (Exact name of registrant as speci |
|
| December 12, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 18, 2023 Khosla Ventures Acquisition Co. (Exact name of registrant as specified in its charter) Delaware 001-40131 86-1488707 (State or other jurisdiction of incorporation) (Co |
|
| November 14, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Khosla Ventures Acquisition Co. |
|
| August 24, 2023 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 18, 2023 Khosla Ventures Acquisition Co. (Exact name of registrant as specified in its charter) Delaware 001-40131 86-1488707 (State or other jurisdiction of incorporation) (Co |
|
| August 14, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Khosla Ventures Acquisition Co. (Exac |
|
| June 12, 2023 |
Amendment to the Second Amended and Restated Certificate of Incorporation, dated March 4, 2021 EX-3.1 Exhibit 3.1 CERTIFICATE OF AMENDMENT TO THE SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF KHOSLA VENTURES ACQUISITION CO. Khosla Ventures Acquisition Co., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), does hereby certify: 1. The original certificate of incorporation of the Corporation was filed with the Secretary of State of |
|
| June 12, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 6, 2023 Khosla Ventures Acquisition Co. (Exact name of registrant as specified in its charter) Delaware 001-40131 86-1488707 (State or other jurisdiction of incorporation) (Commi |
|
| June 12, 2023 |
EX-10.1 Exhibit 10.1 AMENDMENT NO. 1 TO INVESTMENT MANAGEMENT TRUST AGREEMENT THIS AMENDMENT NO. 1 TO THE INVESTMENT MANAGEMENT TRUST AGREEMENT (this “Amendment”) is made as of June 6, 2023, by and between Khosla Ventures Acquisition Co., a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Trustee”). Capitalized terms contained in th |
|
| June 2, 2023 |
DEFA14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| May 19, 2023 |
DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| May 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 9, 2023 Khosla Ventures Acquisition Co. (Exact name of registrant as specified in its charter) Delaware 001-40131 86-1488707 (State or other jurisdiction of incorporation) (Commis |
|
| May 15, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Khosla Ventures Acquisition Co. (Exa |
|
| May 12, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission |
|
| May 5, 2023 |
PRE 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| March 31, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31 , 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-4 |
|
| March 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 7, 2023 Khosla Ventures Acquisition Co. (Exact name of registrant as specified in its charter) Delaware 001-40131 86-1488707 (State or other jurisdiction of incorporation) (Comm |
|
| February 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 14, 2023 Khosla Ventures Acquisition Co. (Exact name of registrant as specified in its charter) Delaware 001-40131 86-1488707 (State or other jurisdiction of incorporation) ( |
|
| February 14, 2023 |
KVSA / Khosla Ventures Acquisition Co. Class A / Sculptor Capital LP - SC 13G/A Passive Investment SC 13G/A 1 d436477dsc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* KHOSLA VENTURES ACQUISITION CO. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 482504107 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of th |
|
| February 14, 2023 |
KVSA / Khosla Ventures Acquisition Co. Class A / CITADEL ADVISORS LLC - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 (Amendment No. 2)* Khosla Ventures Acquisition Co. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (the “Shares”) (Title of Class of Securi |
|
| February 10, 2023 |
KVSA / Khosla Ventures Acquisition Co. Class A / Weiss Asset Management LP Passive Investment Converted by EDGARwiz =============================================================================== UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| November 14, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Khosla Ventures Acquisition Co. |
|
| August 11, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Khosla Ventures Acquisition Co. (Exac |
|
| May 13, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Khosla Ventures Acquisition Co. (Exact name of registr |
|
| April 1, 2022 |
Exhibit 4.2 DESCRIPTION OF REGISTRANT?S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 Khosla Ventures Acquisition Co. (?company,? ?we,? ?us,? or ?our?) has one class of securities registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (the ?Exchange Act?), its Class A common stock, $0.0001 par value per share. The following is a s |
|
| April 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-CEN ? Form N-CSR For Period Ended: December 31, 2021 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q For the Transition Period Ended: Read Instruction (on back page) Before Preparing Form. |
|
| April 1, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-40 |
|
| March 14, 2022 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 4, 2022 Khosla Ventures Acquisition Co. (Exact name of registrant as specified in its charter) Delaware 001-40131 86-1488707 (State or other jurisdiction of incorporation) (Comm |
|
| February 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO ? 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO ? 240.13d-2 (Amendment No. 1)* Khosla Ventures Acquisition Co. (Name of Issuer) Class A common stock, par value $0.0001 per share (the ?Shares?) (Title of Class of Securi |
|
| February 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 10, 2022 Khosla Ventures Acquisition Co. (Exact name of registrant as specified in its charter) Delaware 001-40131 86-1488707 (State or other jurisdiction of incorporation) ( |
|
| February 11, 2022 |
KVSA / Khosla Ventures Acquisition Co. Class A / Weiss Asset Management LP Passive Investment =============================================================================== UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| February 2, 2022 |
KVSA / Khosla Ventures Acquisition Co. Class A / Sculptor Capital LP - SC 13G Passive Investment SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* KHOSLA VENTURES ACQUISITION CO. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 482504107 (CUSIP Number) January 24, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriat |
|
| January 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (AMENDMENT NO. 1) KHOSLA VENTURES ACQUISITION CO. III (Name of Issuer) CLASS A COMMON STOCK, PAR VALUE $0.0001 PER SHARE (Title of Class of Securities) 482506102 (CUSIP Number) DECEMBER 31, 2021 (Date of event which requires filing of this statement) Check the appropriate |
|
| January 18, 2022 |
SC 13G/A 1 KVSAS13GA1.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (AMENDMENT NO. 1) KHOSLA VENTURES ACQUISITION CO. (Name of Issuer) CLASS A COMMON STOCK, PAR VALUE $0.0001 PER SHARE (Title of Class of Securities) 482504107 (CUSIP Number) DECEMBER 31, 2021 (Date of event which requires filing of this statement) |
|
| November 29, 2021 |
KVSA / Khosla Ventures Acquisition Co. Class A / CITADEL ADVISORS LLC - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 (Amendment No. )* Khosla Ventures Acquisition Co. (Name of Issuer) Class A common stock, par value $0.0001 per share (Title of Class of Securities) 482504107 |
|
| November 29, 2021 |
EXHIBIT 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that the Statement on Schedule 13G filed herewith (and any amendments thereto), relating to the Class A common stock of Khosla Ventures Acquisition Co., a Delaware corporation, is being filed jointly with the Securities and Exchange Commission pursuant to Rule 13d-1(c) under the Securities Exchange Act of 1934, as amended, on behalf |
|
| November 15, 2021 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Valo Health and Khosla Ventures Acquisition Co. Mutually Agree to Terminate Business Combination Agreement BOSTON and MENLO PARK, Calif., November 15, 2021 ? Valo Health, LLC (?Valo?), the technology company using human-centric data and artificial intelligence (AI) powered computation to transform the drug discovery and development process and Khosla Ventures Acq |
|
| November 15, 2021 |
Termination of a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 15, 2021 Khosla Ventures Acquisition Co. (Exact name of registrant as specified in its charter) Delaware 001-40131 86-1488707 (State or other jurisdiction of incorporation) ( |
|
| November 9, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 8, 2021 Khosla Ventures Acquisition Co. (Exact name of registrant as specified in its charter) Delaware 001-40131 86-1488707 (State or other jurisdiction of incorporation) (C |
|
| November 9, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 8, 2021 Khosla Ventures Acquisition Co. (Exact name of registrant as specified in its charter) Delaware 001-40131 86-1488707 (State or other jurisdiction of incorporation) (C |
|
| November 9, 2021 |
Valo Health and Khosla Ventures Acquisition Co. Announce Additional PIPE Commitments Exhibit 99.1 Valo Health and Khosla Ventures Acquisition Co. Announce Additional PIPE Commitments ? Additional PIPE commitments since SPAC announcement total $33.5M ? Anticipated PIPE proceeds total over $200M exceeding initial targets ? New commitments made by CEO & Founder, David Berry and CFO, Graeme Bell BOSTON, MA and MENLO PARK, CA, November 9, 2021 ? Valo Health, LLC (?Valo?), the technolog |
|
| November 8, 2021 |
Filed by Khosla Ventures Acquisition Co. Filed by Khosla Ventures Acquisition Co. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Khosla Ventures Acquisition Co. Commission File No. 001-40131 Chris Katje: Joining us on SPACs Attack we have David Berry, the founder and CEO of Valo Health company merging with Khosla Ventures Acquisition t |
|
| November 5, 2021 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Khosla Ventures Acquisition Co. |
|
| October 28, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 22, 2021 Khosla Ventures Acquisition Co. (Exact name of registrant as specified in its charter) Delaware 001-40131 85-1488707 (State or other jurisdiction of incorporation) (C |
|
| October 28, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 22, 2021 Khosla Ventures Acquisition Co. (Exact name of registrant as specified in its charter) Delaware 001-40131 85-1488707 (State or other jurisdiction of incorporation) (C |
|
| October 28, 2021 |
Exhibit 99.1 Khosla Ventures Acquisition Co. Announces Planned Transfer of Listing to NYSE in Connection with its Proposed Business Combination with Valo Health BOSTON, MA and MENLO PARK, CA, October 28, 2021 ? Khosla Ventures Acquisition Co. (Nasdaq:KVSA) (?KVSA?), a special purpose acquisition company sponsored by an affiliate of Khosla Ventures, LLC (?Khosla Ventures?), today announced that it |
|
| October 25, 2021 |
Filed by Khosla Ventures Acquisition Co. Filed by Khosla Ventures Acquisition Co. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Khosla Ventures Acquisition Co. Commission File No. 001-40131 Khosla Ventures Acquisition Co. announces Special Meeting of Stockholders to approve business combination with Valo Health Special Meeting of Stoc |
|
| October 22, 2021 |
Table of Contents Filed Pursuant to Rule 424(b)(3) Registration No. 333-257591 PROXY STATEMENT FOR SPECIAL MEETING OF KHOSLA VENTURES ACQUISITION CO. (A DELAWARE CORPORATION) PROSPECTUS FOR 236,455,190 SHARES OF CLASS A COMMON STOCK OF KHOSLA VENTURES ACQUISITION CO. (WHICH WILL BE RENAMED ?VALO HEALTH HOLDINGS, INC.? IN CONNECTION WITH THE BUSINESS COMBINATION DESCRIBED HEREIN) On June 9, 2021, w |
|
| October 20, 2021 |
Specimen Common Stock Certificate of Valo Health Holdings, Inc. Exhibit 4.2 SEE REVERSE FOR IMPORTANT NOTICE REGARDING OWNERSHIP AND TRANSFER RESTRICTIONS AND CERTAIN OTHER INFORMATION INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE ORDINARY STOCK CUSIP 0000000 00 0 SEE REVERSE FOR CERTAIN DEFINITIONS THIS CERTIFIES THAT IS THE OWNER OF SPECIMEN FULLY PAID AND NON-ASSESSABLE SHARES OF THE CLASS A COMMON STOCK $0.0001 PAR VALUE, OF VALO HEALTH HOLDINGS, IN |
|
| October 20, 2021 |
Valo Health, Inc. 2021 Stock Option and Grant Plan Exhibit 10.19 VALO HEALTH, INC. 2021 STOCK OPTION AND GRANT PLAN SECTION 1. GENERAL PURPOSE OF THE PLAN; DEFINITIONS The name of the plan is the Valo Health, Inc. 2021 Stock Option and Grant Plan (the ?Plan?). The purpose of the Plan is to encourage and enable the officers, employees, directors, Consultants and other key persons of Valo Health, Inc., a Delaware corporation (including any successor |
|
| October 20, 2021 |
Consent of Brett Chugg to be named as a director Exhibit 99.7 CONSENT In connection with the filing by Khosla Ventures Acquisition Co. of the Registration Statement on Form S-4 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the ?Securities Act?), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named in the Registration Statement and any and all amendments and supplements thereto a |
|
| October 20, 2021 |
Consent of David R. Epstein to be named as a director Exhibit 99.5 CONSENT In connection with the filing by Khosla Ventures Acquisition Co. of the Registration Statement on Form S-4 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the ?Securities Act?), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named in the Registration Statement and any and all amendments and supplements thereto a |
|
| October 20, 2021 |
Consent of Ronald W. Hovsepian to be named as a director Exhibit 99.8 CONSENT In connection with the filing by Khosla Ventures Acquisition Co. of the Registration Statement on Form S-4 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the ?Securities Act?), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named in the Registration Statement and any and all amendments and supplements thereto a |
|
| October 20, 2021 |
KHOSLA VENTURES ACQUISITION CO. 2128 Sand Hill Road Menlo Park, California, 94025 KHOSLA VENTURES ACQUISITION CO. 2128 Sand Hill Road Menlo Park, California, 94025 October 20, 2021 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Alan Campbell; Celeste Murphy Re: Khosla Ventures Acquisition Co. Registration Statement on Form S-4 File No. 333-257591 Ladies and Gentlemen: Pursuant to Rule 461 of Regulatio |
|
| October 20, 2021 |
Consent of Samir Kaul to be named as a director Exhibit 99.2 CONSENT In connection with the filing by Khosla Ventures Acquisition Co. of the Registration Statement on Form S-4 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the ?Securities Act?), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named in the Registration Statement and any and all amendments and supplements thereto a |
|
| October 20, 2021 |
License Agreement between Sanofi and Valo Health, Inc. dated as of May 10, 2021 Exhibit 10.23 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED AND REPLACED WITH ?[***]?. SUCH IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. EXECUTION VERSION LICENSE AGREEMENT between SANOFI and VALO HEALTH, INC. Dated as of May 10, 2021 TABLE OF CONTENTS ARTICLE |
|
| October 20, 2021 |
As filed with the Securities and Exchange Commission on October 20, 2021 Table of Contents As filed with the Securities and Exchange Commission on October 20, 2021 Registration No. |
|
| October 20, 2021 |
Form of Proxy Card for Special Meeting Exhibit 99.1 KHOSLA VENTURES ACQUISITION CO. 2128 SAND HILL ROAD MENLO PARK, CA 94025 VOTE BY INTERNET Before The Meeting - Go to www.proxyvote.com Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 p.m. Eastern Time the day before the cut-off date or meeting date. Have your proxy card in hand when you access the web site and follow the |
|
| October 20, 2021 |
License Agreement between Sanofi and Valo Health, Inc. dated as of February 8, 2021 Exhibit 10.22 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED AND REPLACED WITH ?[***]?. SUCH IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. EXECUTION VERSION LICENSE AGREEMENT between SANOFI and VALO HEALTH, INC. Dated as of February 8, 2021 TABLE OF CONTENTS ARTI |
|
| October 20, 2021 |
Consent of Shreeram Aradhye, M.D. to be named as a director Exhibit 99.6 CONSENT In connection with the filing by Khosla Ventures Acquisition Co. of the Registration Statement on Form S-4 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the ?Securities Act?), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named in the Registration Statement and any and all amendments and supplements thereto a |
|
| October 20, 2021 |
Consent of Harsha Ramalingam to be named as a director Exhibit 99.9 CONSENT In connection with the filing by Khosla Ventures Acquisition Co. of the Registration Statement on Form S-4 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the ?Securities Act?), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named in the Registration Statement and any and all amendments and supplements thereto a |
|
| October 20, 2021 |
Consent of Judy Lewent to be named as a director Exhibit 99.4 CONSENT In connection with the filing by Khosla Ventures Acquisition Co. of the Registration Statement on Form S-4 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the ?Securities Act?), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named in the Registration Statement and any and all amendments and supplements thereto a |
|
| October 20, 2021 |
Consent of David A. Berry, M.D., Ph.D. to be named as a director Exhibit 99.3 CONSENT In connection with the filing by Khosla Ventures Acquisition Co. of the Registration Statement on Form S-4 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the ?Securities Act?), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named in the Registration Statement and any and all amendments and supplements thereto a |
|
| October 8, 2021 |
Offer Letter between the Company and Hilary Malone dated April 21, 2021 Exhibit 10.25 April 21, 2021 Hilary Malone *** Re: Valo Health, Inc. Employment Letter Dear Hilary: On behalf of Valo Health, Inc., together with its affiliates (the ?Company?), this letter sets forth the terms of your employment with the Company (the ?Employment Letter?). This Employment Letter and accompanying documents and agreements summarize and set forth important terms about your employment |
|
| October 8, 2021 |
Offer Letter between the Company and David Berry dated August 19, 2021 Exhibit 10.27 Execution Version August 19, 2021 David Berry *** Re: Valo Health, Inc. Employment Letter Dear David: On behalf of Valo Health, Inc., together with its affiliates and any successor thereto (the ?Company?), this letter sets forth the terms of your employment with the Company (the ?Employment Letter?). This Employment Letter and accompanying documents and agreements summarize and set f |
|
| October 8, 2021 |
As filed with the Securities and Exchange Commission on October 8, 2021 Table of Contents As filed with the Securities and Exchange Commission on October 8, 2021 Registration No. |
|
| October 8, 2021 |
Khosla Ventures Acquisition Co. 2128 Sand Hill Road Menlo Park, CA 94025 Khosla Ventures Acquisition Co. 2128 Sand Hill Road Menlo Park, CA 94025 October 8, 2021 VIA EDGAR Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Division of Corporation Finance Attention: Alan Campbell; Celeste Murphy Re: Khosla Ventures Acquisition Co. Amendment No. 1 to Registration Statement on Form S-4 Filed September 22, 2021 File No. 333-257591 Dear Mr. Campbel |
|
| October 8, 2021 |
Offer Letter between the Company and Cissy Young dated April 21, 2021 Exhibit 10.26 April 21, 2021 Cissy Young *** Re: Valo Health, Inc. Employment Letter Dear Cissy: On behalf of Valo Health, Inc., together with its affiliates (the ?Company?), this letter sets forth the terms of your employment with the Company (the ?Employment Letter?). This Employment Letter and accompanying documents and agreements summarize and set forth important terms about your employment wi |
|
| September 22, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 22, 2021 Khosla Ventures Acquisition Co. (Exact name of registrant as specified in its charter) Delaware 001-40131 85-1488707 (State or other jurisdiction of incorporation) |
|
| September 22, 2021 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 22, 2021 Khosla Ventures Acquisition Co. (Exact name of registrant as specified in its charter) Delaware 001-40131 85-1488707 (State or other jurisdiction of incorporation) |
|
| September 22, 2021 |
Khosla Ventures Acquisition Co. 2128 Sand Hill Road Menlo Park, CA 94025 Khosla Ventures Acquisition Co. 2128 Sand Hill Road Menlo Park, CA 94025 September 22, 2021 VIA EDGAR Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Division of Corporation Finance Attention: Alan Campbell; Celeste Murphy Re: Khosla Ventures Acquisition Co. Registration Statement on Form S-4 Filed July 1, 2021 File No. 333-257591 Dear Mr. Campbell and Ms. Murphy: This |
|
| September 22, 2021 |
Amendment No. 1 to Agreement and Plan of Merger, dated as of September 22, 2021. EX-2.1 2 d234971dex21.htm EX-2.1 Exhibit 2.1 AMENDMENT NO. 1 TO AGREEMENT AND PLAN OF MERGER THIS AMENDMENT NO. 1 TO AGREEMENT AND PLAN OF MERGER (this “Amendment”) is made as of September 22, 2021 (the “Amendment Date”) by and among Khosla Ventures Acquisition Co., a Delaware corporation (“Acquiror”), Killington Merger Sub Inc., a Delaware corporation and a direct wholly owned subsidiary of Acqui |
|
| September 22, 2021 |
Offer Letter between the Company and Hilary Malone dated April 21, 2021 Exhibit 10.25 April 21, 2021 Hilary Malone *** Re: Valo Health, Inc. Employment Letter Dear Hilary: On behalf of Valo Health, Inc., together with its affiliates (the ?Company?), this letter sets forth the terms of your employment with the Company (the ?Employment Letter?). This Employment Letter and accompanying documents and agreements summarize and set forth important terms about your employment |
|
| September 22, 2021 |
Offer Letter between the Company and David Berry dated August 19, 2021 Exhibit 10.27 Execution Version August 19, 2021 David Berry *** Re: Valo Health, Inc. Employment Letter Dear David: On behalf of Valo Health, Inc., together with its affiliates and any successor thereto (the ?Company?), this letter sets forth the terms of your employment with the Company (the ?Employment Letter?). This Employment Letter and accompanying documents and agreements summarize and set f |
|
| September 22, 2021 |
Offer Letter between the Company and Cissy Young dated April 21, 2021 Exhibit 10.26 April 21, 2021 Cissy Young *** Re: Valo Health, Inc. Employment Letter Dear Cissy: On behalf of Valo Health, Inc., together with its affiliates (the ?Company?), this letter sets forth the terms of your employment with the Company (the ?Employment Letter?). This Employment Letter and accompanying documents and agreements summarize and set forth important terms about your employment wi |
|
| September 22, 2021 |
Table of Contents As filed with the Securities and Exchange Commission on September 2 2 , 2021 Registration No. |
|
| September 13, 2021 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Khosla Ventures Acquisition Co. (Exac |
|
| September 13, 2021 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Khosla Ventures Acquisition Co. (E |
|
| September 1, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 KHOSLA VENTURES ACQUISITION CO. (Name of Issuer) CLASS A COMMON STOCK, PAR VALUE $0.0001 PER SHARE (Title of Class of Securities) 482504107 (CUSIP Number) AUGUST 23, 2021 (Date of event which requires filing of this statement) Check the appropriate box to designate the rul |
|
| September 1, 2021 |
United States SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 31, 2021 Date of Report (Date of earliest event reported) Khosla Ventures Acquisition Co. (Exact Name of Registrant as Specified in its Charter) Delaware 001-40131 85-1488707 (State or other jurisdiction of incorporation) (Com |
|
| August 31, 2021 |
United States SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 25, 2021 Date of Report (Date of earliest event reported) Khosla Ventures Acquisition Co. (Exact Name of Registrant as Specified in its Charter) Delaware 001-40131 85-1488707 (State or other jurisdiction of incorporation) (Com |
|
| August 31, 2021 |
Exhibit 99.1 Khosla Ventures Acquisition Co. Receives Expected Notice From Nasdaq Regarding Delayed Quarterly Report MENLO PARK, August 31, 2021 /PRNewswire/ ? Khosla Ventures Acquisition Co. (the ?Company?) announced today that, on August 25, 2021, it received a notice (?Notice?) from the Listing Qualifications Department of The Nasdaq Stock Market (?Nasdaq?) stating that the Company is not in co |
|
| August 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-CEN ? Form N-CSR For Period Ended: June 30, 2021 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q For the Transition Period Ended: Read Instruction (on back page) Before Preparing Form. |
|
| August 12, 2021 |
Letter dated August 12, 2021 from Marcum LLP Exhibit 16.1 August 12, 2021 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Commissioners: We have read the statements made by Khosla Ventures Acquisition Co. under Item 4.01 of its Form 8-K dated August 12, 2021. We agree with the statements concerning our Firm in such Form 8-K; we are not in a position to agree or disagree with other statements of Khosla Ventures Acqu |
|
| August 12, 2021 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 8, 2021 Khosla Ventures Acquisition Co. (Exact name of registrant as specified in its charter) Delaware 001-40131 85-1488707 (State or other jurisdiction of incorporation) (Com |
|
| July 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 30, 2021 Khosla Ventures Acquisition Co. (Exact name of registrant as specified in its charter) Delaware 001-40131 85-1488707 (State or other jurisdiction of incorporation) (Comm |
|
| July 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 30, 2021 Khosla Ventures Acquisition Co. (Exact name of registrant as specified in its charter) Delaware 001-40131 85-1488707 (State or other jurisdiction of incorporation) (Comm |
|
| July 27, 2021 |
Filed by Khosla Ventures Acquisition Co. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Khosla Ventures Acquisition Co. Commission File No. 001-40131 FOR IMMEDIATE RELEASE Valo Health Announces the Acquisition of Courier Therapeutics Expands capabilities of Valo?s proprietary Opal Computational |
|
| July 20, 2021 |
Filed by Khosla Ventures Acquisition Co. 425 Filed by Khosla Ventures Acquisition Co. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Khosla Ventures Acquisition Co. Commission File No. 001-40131 Valo Analyst Day Presentation Q3 2021Valo Analyst Day Presentation Q3 2021 Disclaimer Disclaimer. This presentation (“Presentation ”) is for i |
|
| July 1, 2021 |
Filed by Khosla Ventures Acquisition Co. Filed by Khosla Ventures Acquisition Co. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Khosla Ventures Acquisition Co. Commission File No. 001-40131 Valo?s Next Chapter Lunch & Learn #2 July 1, 2021 Proprietary and Confidential Disclaimer Proprietary and Confidential Additional Information and |
|
| July 1, 2021 |
Power of Attorney (included on signature page of the Registration Statement) Table of Contents As filed with the Securities and Exchange Commission on June 30, 2021 Registration No. |
|
| June 24, 2021 |
Filed by Khosla Ventures Acquisition Co. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Khosla Ventures Acquisition Co. Commission File No. 001-40131 FOR IMMEDIATE RELEASE Valo Health June 24, 2021 Valo Health Welcomes Leading Life Sciences and Technology Expert Judy Lewent to Board of Directors |
|
| June 21, 2021 |
Filed by Khosla Ventures Acquisition Co. Filed by Khosla Ventures Acquisition Co. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Khosla Ventures Acquisition Co. Commission File No. 001-40131 Valo?s Next Chapter Lunch and Learn June 21, 2021 Proprietary and Confidential Disclaimer Proprietary and Confidential Additional Information and |
|
| June 14, 2021 |
Filed by Khosla Ventures Acquisition Co. Filed by Khosla Ventures Acquisition Co. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Khosla Ventures Acquisition Co. Commission File No. 001-40131 Valo Overview company overview 2021 Disclaimer. This presentation (?Presentation ?) is for informational purposes only to assist interested partie |
|
| June 9, 2021 |
Exhibit 99.1 DRAFT FOR IMMEDIATE RELEASE Valo Health and Khosla Ventures Acquisition Co. to Combine and Create Publicly Traded Company Focused on Transforming the Drug Discovery and Development Process ? Valo is building a fully integrated end-to-end human-centric AI-driven drug discovery platform that aims to improve the success rates for the discovery, development and approval of new drugs ? Tra |
|
| June 9, 2021 |
Exhibit 99.2 Valo Overview Company Overview 2Q21Exhibit 99.2 Valo Overview Company Overview 2Q21 Disclaimer Disclaimer. This presentation (?Presentation ?) is for informational purposes only to assist interested parties in making their own evaluation with respect to the proposed business combination (the ?Business Combination?) between Khosla Ventures Acquisition Co. (?Khosla?) and Valo Health, LL |
|
| June 9, 2021 |
Sponsor Vesting Agreement, dated as of June 9, 2021 Exhibit 10.2 Execution Version SPONSOR VESTING AGREEMENT This SPONSOR VESTING AGREEMENT (this ?Agreement?), dated as of June 9, 2021, is made by and between Khosla Ventures SPAC Sponsor LLC, a Delaware limited liability company (the ?Sponsor?), Khosla Ventures Acquisition Co., a Delaware corporation (the ?Company?), Valo Health, LLC, a Delaware limited liability company (?Valo Health Holdco?) and |
|
| June 9, 2021 |
Form of Subscription Agreement Exhibit 10.1 SUBSCRIPTION AGREEMENT This SUBSCRIPTION AGREEMENT (this ?Subscription Agreement?) is entered into on [ ? ], 2021, by and between Khosla Ventures Acquisition Co., a Delaware corporation (?KVSA?), and the undersigned subscriber (the ?Investor?). WHEREAS, this Subscription Agreement is being entered into in connection with the Agreement and Plan of Merger, dated as of the date hereof (a |
|
| June 9, 2021 |
Filed by Khosla Ventures Acquisition Co. Filed by Khosla Ventures Acquisition Co. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Khosla Ventures Acquisition Co. Commission File No. 001-40131 Dear Valo partner, [I wanted to share the great news with you that?] OR [It is with great enthusiasm that I share that] Valo Health has entered in |
|
| June 9, 2021 |
Filed by Khosla Ventures Acquisition Co. Filed by Khosla Ventures Acquisition Co. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Khosla Ventures Acquisition Co. Commission File No. 001-40131 All, It is with great pleasure and tremendous pride that I share that Valo Health has entered into an agreement to go public through Khosla Ventur |
|
| June 9, 2021 |
Agreement and Plan of Merger, dated as of June 9, 2021 Exhibit 2.1 AGREEMENT AND PLAN OF MERGER by and among KHOSLA VENTURES ACQUISITION CO., KILLINGTON MERGER SUB INC., VALO HEALTH, LLC and VALO HEALTH, INC. dated as of June 9, 2021 TABLE OF CONTENTS Page ARTICLE I CERTAIN DEFINITIONS Section 1.1. Definitions 3 Section 1.2. Construction 19 Section 1.3. Knowledge 19 ARTICLE II THE MERGER; CLOSING Section 2.1. The Merger 20 Section 2.2. Effects of the |
|
| June 9, 2021 |
Member Support Agreement, dated as of June 9, 2021 Exhibit 10.4 Execution Version MEMBER SUPPORT AGREEMENT This Member Support Agreement (this ?Agreement?) is dated as of June 9, 2021, by and among Khosla Ventures Acquisition Co., a Delaware corporation (?Acquiror?), the Persons set forth on Schedule I hereto (each, a ?Member? and, collectively, the ?Members?), Valo Health, LLC, a Delaware limited liability company (?Company Holdco?) and Valo Heal |
|
| June 9, 2021 |
Sponsor Support Agreement, dated as of June 9, 2021 Exhibit 10.3 Execution Version SPONSOR SUPPORT AGREEMENT This Sponsor Support Agreement (this ?Sponsor Agreement?) is dated as of June 9, 2021, by and among Khosla Ventures SPAC Sponsor LLC, a Delaware limited liability company (the ?Sponsor Holdco?), the Persons set forth on Schedule I hereto (together with the Sponsor Holdco, each, a ?Sponsor? and, together, the ?Sponsors?), Khosla Ventures Acqu |
|
| June 9, 2021 |
425 1 d584526d8k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 9, 2021 Khosla Ventures Acquisition Co. (Exact name of registrant as specified in its charter) Delaware 001-40131 85-1488707 (State or other jurisdiction |
|
| June 9, 2021 |
Exhibit 99.4 Filed by Khosla Ventures Acquisition Co. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Khosla Ventures Acquisition Co. Commission File No. 001-40131 Valo and KVAC Investor Presentation Transcript Script Full Deck slides 5-22 SK: Good Morning, and thank you for being with us today. |
|
| June 9, 2021 |
Exhibit 99.4 Filed by Khosla Ventures Acquisition Co. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Khosla Ventures Acquisition Co. Commission File No. 001-40131 Valo and KVAC Investor Presentation Transcript Script Full Deck slides 5-22 SK: Good Morning, and thank you for being with us today. |
|
| June 9, 2021 |
Sponsor Support Agreement, dated as of June 9, 2021 Exhibit 10.3 Execution Version SPONSOR SUPPORT AGREEMENT This Sponsor Support Agreement (this ?Sponsor Agreement?) is dated as of June 9, 2021, by and among Khosla Ventures SPAC Sponsor LLC, a Delaware limited liability company (the ?Sponsor Holdco?), the Persons set forth on Schedule I hereto (together with the Sponsor Holdco, each, a ?Sponsor? and, together, the ?Sponsors?), Khosla Ventures Acqu |
|
| June 9, 2021 |
Sponsor Vesting Agreement, dated as of June 9, 2021 Exhibit 10.2 Execution Version SPONSOR VESTING AGREEMENT This SPONSOR VESTING AGREEMENT (this ?Agreement?), dated as of June 9, 2021, is made by and between Khosla Ventures SPAC Sponsor LLC, a Delaware limited liability company (the ?Sponsor?), Khosla Ventures Acquisition Co., a Delaware corporation (the ?Company?), Valo Health, LLC, a Delaware limited liability company (?Valo Health Holdco?) and |
|
| June 9, 2021 |
Exhibit 10.1 SUBSCRIPTION AGREEMENT This SUBSCRIPTION AGREEMENT (this ?Subscription Agreement?) is entered into on [ ? ], 2021, by and between Khosla Ventures Acquisition Co., a Delaware corporation (?KVSA?), and the undersigned subscriber (the ?Investor?). WHEREAS, this Subscription Agreement is being entered into in connection with the Agreement and Plan of Merger, dated as of the date hereof (a |
|
| June 9, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 9, 2021 Khosla Ventures Acquisition Co. (Exact name of registrant as specified in its charter) Delaware 001-40131 85-1488707 (State or other jurisdiction of incorporation) (Commi |
|
| June 9, 2021 |
Member Support Agreement, dated as of June 9, 2021 Exhibit 10.4 Execution Version MEMBER SUPPORT AGREEMENT This Member Support Agreement (this ?Agreement?) is dated as of June 9, 2021, by and among Khosla Ventures Acquisition Co., a Delaware corporation (?Acquiror?), the Persons set forth on Schedule I hereto (each, a ?Member? and, collectively, the ?Members?), Valo Health, LLC, a Delaware limited liability company (?Company Holdco?) and Valo Heal |
|
| June 9, 2021 |
Exhibit 99.3 Valo Overview: Supplemental Content 2Q21Exhibit 99.3 Valo Overview: Supplemental Content 2Q21 Disclaimer Disclaimer. This presentation (?Presentation ?) is for informational purposes only to assist interested parties in making their own evaluation with respect to the proposed business combination (the ?Business Combination?) between Khosla Ventures Acquisition Co. (?Khosla?) and Valo |
|
| June 9, 2021 |
Exhibit 99.2 Valo Overview Company Overview 2Q21Exhibit 99.2 Valo Overview Company Overview 2Q21 Disclaimer Disclaimer. This presentation (?Presentation ?) is for informational purposes only to assist interested parties in making their own evaluation with respect to the proposed business combination (the ?Business Combination?) between Khosla Ventures Acquisition Co. (?Khosla?) and Valo Health, LL |
|
| June 9, 2021 |
Exhibit 99.1 DRAFT FOR IMMEDIATE RELEASE Valo Health and Khosla Ventures Acquisition Co. to Combine and Create Publicly Traded Company Focused on Transforming the Drug Discovery and Development Process ? Valo is building a fully integrated end-to-end human-centric AI-driven drug discovery platform that aims to improve the success rates for the discovery, development and approval of new drugs ? Tra |
|
| June 9, 2021 |
Agreement and Plan of Merger, dated as of June 9, 2021 Exhibit 2.1 AGREEMENT AND PLAN OF MERGER by and among KHOSLA VENTURES ACQUISITION CO., KILLINGTON MERGER SUB INC., VALO HEALTH, LLC and VALO HEALTH, INC. dated as of June 9, 2021 TABLE OF CONTENTS Page ARTICLE I CERTAIN DEFINITIONS Section 1.1. Definitions 3 Section 1.2. Construction 19 Section 1.3. Knowledge 19 ARTICLE II THE MERGER; CLOSING Section 2.1. The Merger 20 Section 2.2. Effects of the |
|
| June 9, 2021 |
Valo Health Brand Channel Posts Filed by Khosla Ventures Acquisition Co. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Khosla Ventures Acquisition Co. Commission File No. 001-40131 Valo Health Announcement Social Media Content Recommended Social Media Copy Account Platform Announcement Day Valo Health Brand Channel Posts Twit |
|
| June 9, 2021 |
EX-99.3 9 d584526dex993.htm EX-99.3 Exhibit 99.3 Valo Overview: Supplemental Content 2Q21Exhibit 99.3 Valo Overview: Supplemental Content 2Q21 Disclaimer Disclaimer. This presentation (“Presentation ”) is for informational purposes only to assist interested parties in making their own evaluation with respect to the proposed business combination (the “Business Combination”) between Khosla Ventures |
|
| June 9, 2021 |
Filed by Khosla Ventures Acquisition Co. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Khosla Ventures Acquisition Co. Commission File No. 001-40131 Khosla & Valo Health createan industry-defining opportunityKhosla Ventures (KV)Venture capital investors in industry-definingcompanies that have c |
|
| May 25, 2021 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Khosla Ventures Acquisition Co. (Exa |
|
| May 18, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-CEN ? Form N-CSR For Period Ended: March 31, 2021 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q For the Transition Period Ended: Read Instruction (on back page) Before Preparing Form. |
|
| March 30, 2021 |
Voting Agreement, dated as of March 26, 2021 Exhibit 10.1 KHOSLA VENTURES ACQUISITION CO. SPONSOR VOTING AGREEMENT This Sponsor Voting Agreement (this ?Agreement?) is made as of March 26, 2021, by and among Khosla Ventures Acquisiton Co., a Delaware corporation (the ?SPAC?) and Khosla Ventures SPAC Sponsor, LLC, a Delaware limited liability company (the ?Sponsor?). WHEREAS, pursuant to Section 7.9 of the Second Amended and Restated Certifica |
|
| March 30, 2021 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 26, 2021 Khosla Ventures Acquisition Co. (Exact name of registrant as specified in its charter) Delaware 001-40131 85-1488707 (State or other jurisdiction (Commission (I.R.S. Em |
|
| March 15, 2021 |
EX-99.1 Exhibit 99.1 INDEX TO FINANCIAL STATEMENT Page Report of Independent Registered Public Accounting Firm F-2 Balance Sheet as of March 8, 2021 F-3 Notes to Financial Statement F-4 F-1 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Shareholders and Board of Directors of Khosla Ventures Acquisition Co. Opinion on the Financial Statement We have audited the accompanying balance |
|
| March 15, 2021 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 8, 2021 Khosla Ventures Acquisition Co. (Exact name of registrant as specified in its charter) Delaware 001-40131 85-1488707 (State or other jurisdiction of incorporation) (Comm |
|
| March 9, 2021 |
Second Amended and Restated Certificate of Incorporation, dated March 4, 2021 Exhibit 3.1 SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF KHOSLA VENTURES ACQUISITION CO. Khosla Ventures Acquisition Co., a corporation under the laws of the State of Delaware (the ?Corporation?), does make, file, and record this Amended and Restated Certificate of Incorporation (the ?Certificate?), and does hereby certify as follows: 1. The name of the Corporation is Khosla Venture |
|
| March 9, 2021 |
Forward Purchase Agreement, dated March 3, 2021, among the Company and the Sponsor Exhibit 10.4 FORWARD PURCHASE AGREEMENT This Forward Purchase Agreement (this ?Agreement?) is entered into as of March 3, 2021, between Khosla Ventures Acquisition Co., a Delaware corporation (the ?Company?), and Khosla Ventures SPAC Sponsor LLC, a Delaware limited liability company (the ?Purchaser?). RECITALS WHEREAS, the Company was formed for the purpose of effecting a merger, capital stock exc |
|
| March 9, 2021 |
Exhibit 10.1 INVESTMENT MANAGEMENT TRUST AGREEMENT This Investment Management Trust Agreement (this ?Agreement?) is made effective as of March 3, 2021 by and between Khosla Ventures Acquisition Co., a Delaware corporation (the ?Company?) and Continental Stock Transfer & Trust Company, a New York limited purpose trust company (the ?Trustee?). WHEREAS, the Company?s registration statement on Form S- |
|
| March 9, 2021 |
Exhibit 10.3 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this ?Agreement?), dated as of March 3, 2021, is made and entered into by and among Khosla Ventures Acquisition Co., a Delaware corporation (the ?Company?), Khosla Ventures SPAC Sponsor LLC, a Delaware limited liability company (the ?Sponsor?), and the undersigned parties listed under Holder on the signature pages heret |
|
| March 9, 2021 |
Khosla Ventures Acquisition Co. Announces Pricing of $300 Million Initial Public Offering EX-99.1 10 d115991dex991.htm EX-99.1 Exhibit 99.1 Khosla Ventures Acquisition Co. Announces Pricing of $300 Million Initial Public Offering MENLO PARK, March 3, 2021 /PRNewswire/ — Khosla Ventures Acquisition Co. (the “Company”), a newly incorporated blank check company whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or simila |
|
| March 9, 2021 |
Private Placement Shares Agreement, dated March 3, 2021, between the Company and the Sponsor EX-10.2 5 d115991dex102.htm EX-10.2 Exhibit 10.2 PRIVATE PLACEMENT SHARES PURCHASE AGREEMENT THIS PRIVATE PLACEMENT SHARES PURCHASE AGREEMENT, dated as of March 3, 2021 (as it may from time to time be amended and including all exhibits referenced herein, this “Agreement”), is entered into by and between Khosla Ventures Acquisition Co., a Delaware corporation (the “Company”) and Khosla Ventures SPA |
|
| March 9, 2021 |
Indemnity Agreement, dated as of March 8, 2021, by and between the Registrant and Derek Anthony West Exhibit 10.6 INDEMNITY AGREEMENT THIS INDEMNITY AGREEMENT (this ?Agreement?) is made as of March 3, 2021, by and between Khosla Ventures Acquisition Co., a Delaware corporation (the ?Company?), and [?] (the ?Indemnitee?). RECITALS WHEREAS, highly competent persons have become more reluctant to serve publicly-held corporations as directors, officers or in other capacities unless they are provided w |
|
| March 9, 2021 |
Exhibit 1.1 Khosla Ventures Acquisition Co. 30,000,000 Shares of Class A Common Stock Underwriting Agreement March 3, 2021 Goldman Sachs & Co. LLC As representative (the ?Representative?) of the several Underwriters named in Schedule I hereto, Goldman Sachs & Co. LLC 200 West Street New York, New York 10282-2198 Ladies and Gentlemen: Khosla Ventures Acquisition Co., a Delaware corporation (the ?Co |
|
| March 9, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 3, 2021 Khosla Ventures Acquisition Co. (Exact name of registrant as specified in its charter) Delaware 001-40131 86-1488707 (State or other jurisdiction of incorporation) (Comm |
|
| March 9, 2021 |
Exhibit 10.5 March 3, 2021 Khosla Ventures Acquisition Co. 2128 Sand Hill Road Menlo Park, California 94025 Re: Initial Public Offering Ladies and Gentlemen: This letter agreement (this ?Letter Agreement?) is being delivered to you in accordance with the underwriting agreement (the ?Underwriting Agreement?) entered into by and between Khosla Ventures Acquisition Co., a Delaware corporation (the ?C |
|
| March 4, 2021 |
Khosla Ventures Acquisition Co. 30,000,000 Shares of Class A Common Stock Table of Contents Filed pursuant to Rule 424(b)(4) Registration No. 333-253096 PROSPECTUS Khosla Ventures Acquisition Co. $300,000,000 30,000,000 Shares of Class A Common Stock Khosla Ventures Acquisition Co. is a newly incorporated blank check company whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combina |
|
| March 1, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 Khosla Ventures Acquisition Co. (Exact name of registrant as specified in its charter) Delaware 86-1488707 (State or other jurisdiction of incorporation or organization) (IRS Employer Identificatio |
|
| March 1, 2021 |
* * * [Signature Page Follows] March 1, 2021 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N. |
|
| March 1, 2021 |
505 Montgomery Street, Suite 2000 San Francisco, California 94111-6538 Tel: +1.415.391.0600 Fax: +1.415.395.8095 www.lw.com FIRM / AFFILIATE OFFICES Beijing Moscow Boston Munich Brussels New York Century City Orange County Chicago Paris Dubai Riyadh March 1, 2021 D?sseldorf San Diego Frankfurt San Francisco Hamburg Seoul Hong Kong Shanghai Via EDGAR Houston Silicon Valley London Singapore Securiti |
|
| March 1, 2021 |
Table of Contents As filed with the U.S. Securities and Exchange Commission on March 1, 2021. Registration No. 333-253096 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 2 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Khosla Ventures Acquisition Co. (Exact name of registrant as specified in its charter) Delaware 6770 86-1488707 (State or |
|
| March 1, 2021 |
Khosla Ventures Acquisition Co. 2128 Sand Hill Road Menlo Park, CA 94025 Khosla Ventures Acquisition Co. 2128 Sand Hill Road Menlo Park, CA 94025 March 1, 2021 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-6010 Re: Khosla Ventures Acquisition Co. Registration Statement on Form S-1 (Registration No. 333-253096) Ladies and Gentlemen: In accordance with Rule 461 of Regulation C of the G |
|
| February 25, 2021 |
Exhibit 10.1 INVESTMENT MANAGEMENT TRUST AGREEMENT This Investment Management Trust Agreement (this ?Agreement?) is made effective as of [?], 2021 by and between Khosla Ventures Acquisition Co., a Delaware corporation (the ?Company?) and Continental Stock Transfer & Trust Company, a New York limited purpose trust company (the ?Trustee?). WHEREAS, the Company?s registration statement on Form S-1, N |
|
| February 25, 2021 |
Form of Forward-purchase Agreement between the Registrant and the Sponsor. Exhibit 10.8 FORWARD PURCHASE AGREEMENT This Forward Purchase Agreement (this ?Agreement?) is entered into as of [?], 2021, between Khosla Ventures Acquisition Co., a Delaware corporation (the ?Company?), [?], a Delaware [?], and [?], a Delaware [?] (together, the ?Purchasers?). RECITALS WHEREAS, the Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisitio |
|
| February 25, 2021 |
As filed with the U.S. Securities and Exchange Commission on February 25, 2021. Registration No. 333-253096 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Khosla Ventures Acquisition Co. (Exact name of registrant as specified in its charter) Delaware 6770 86-1488707 (State or other jurisdic |
|
| February 25, 2021 |
Form of Registration Rights Agreement among the Registrant and certain securityholders. Exhibit 10.2 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this ?Agreement?), dated as of [?], 2021, is made and entered into by and among Khosla Ventures Acquisition Co., a Delaware corporation (the ?Company?), Khosla Ventures SPAC Sponsor LLC, a Delaware limited liability company (the ?Sponsor?), and the undersigned parties listed under Holder on the signature pages hereto (e |
|
| February 25, 2021 |
Form of Underwriting Agreement. Exhibit 1.1 Khosla Ventures Acquisition Co. 30,000,000 Shares of Class A Common Stock Underwriting Agreement [?], 2021 Goldman Sachs & Co. LLC As representative (the ?Representative?) of the several Underwriters named in Schedule I hereto, Goldman Sachs & Co. LLC 200 West Street New York, New York 10282-2198 Ladies and Gentlemen: Khosla Ventures Acquisition Co., a Delaware corporation (the ?Compan |
|
| February 25, 2021 |
Form of Second Amended and Restated Certificate of Incorporation. Exhibit 3.2 SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF KHOSLA VENTURES ACQUISITION CO. Khosla Ventures Acquisition Co., a corporation under the laws of the State of Delaware (the ?Corporation?), does make, file, and record this Amended and Restated Certificate of Incorporation (the ?Certificate?), and does hereby certify as follows: 1. The name of the Corporation is Khosla Venture |
|
| February 25, 2021 |
Specimen Class A Common Stock Certificate Exhibit 4.1 SPECIMEN CLASS A COMMON STOCK CERTIFICATE NUMBER NUMBER C- SHARES SEE REVERSE FOR CERTAIN DEFINITIONS CUSIP KHOSLA VENTURES ACQUISITION CO. INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE CLASS A COMMON STOCK This Certifies that is the owner of FULLY PAID AND NON-ASSESSABLE SHARES OF THE PAR VALUE OF $0.0001 EACH OF THE CLASS A COMMON STOCK OF KHOSLA VENTURES ACQUISITION CO. (THE |
|
| February 25, 2021 |
Exhibit 10.7 [?], 2021 Khosla Ventures Acquisition Co. 2128 Sand Hill Road Menlo Park, California 94025 Re: Initial Public Offering Ladies and Gentlemen: This letter agreement (this ?Letter Agreement?) is being delivered to you in accordance with the underwriting agreement (the ?Underwriting Agreement?) entered into by and between Khosla Ventures Acquisition Co., a Delaware corporation (the ?Compa |
|
| February 25, 2021 |
Exhibit 10.4 INDEMNITY AGREEMENT THIS INDEMNITY AGREEMENT (this ?Agreement?) is made as of [?], 2021, by and between Khosla Ventures Acquisition Co., a Delaware corporation (the ?Company?), and [?] (the ?Indemnitee?). RECITALS WHEREAS, highly competent persons have become more reluctant to serve publicly-held corporations as directors, officers or in other capacities unless they are provided with |
|
| February 25, 2021 |
Form of Private Placement Shares Purchase Agreement between the Registrant and the Sponsor. Exhibit 10.3 PRIVATE PLACEMENT SHARES PURCHASE AGREEMENT THIS PRIVATE PLACEMENT SHARES PURCHASE AGREEMENT, dated as of [?], 2021 (as it may from time to time be amended and including all exhibits referenced herein, this ?Agreement?), is entered into by and between Khosla Ventures Acquisition Co., a Delaware corporation (the ?Company?) and Khosla Ventures SPAC Sponsor LLC, a Delaware limited liabil |
|
| February 12, 2021 |
Power of Attorney (included on page II-8 to the original filing of the Registration Statement). Table of Contents As filed with the U.S. Securities and Exchange Commission on February 12, 2021. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Khosla Ventures Acquisition Co. (Exact name of registrant as specified in its charter) Delaware 6770 86-1488707 (State or other jurisdiction of |
|
| February 12, 2021 |
BYLAWS KHOSLA VENTURES ACQUISITION CO. (THE “CORPORATION”) ARTICLE I Exhibit 3.3 BYLAWS OF KHOSLA VENTURES ACQUISITION CO. (THE ?CORPORATION?) ARTICLE I OFFICES Section 1.1. Registered Office. The registered office of the Corporation within the State of Delaware shall be located at either (a) the principal place of business of the Corporation in the State of Delaware or (b) the office of the corporation or individual acting as the Corporation?s registered agent in |
|
| February 12, 2021 |
Exhibit 99.1 Consent to be Named as a Director Nominee In connection with the filing by Khosla Ventures Acquisition Co. of the Registration Statement on Form S-1 (the “Registration Statement”) with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to t |
|
| February 12, 2021 |
Promissory Note, dated as of January 19, 2021, issued to the sponsor Exhibit 10.5 THIS PROMISSORY NOTE (THIS “NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COM |
|
| February 12, 2021 |
Securities Subscription Agreement, dated January 22, 2021, between the Registrant and the sponsor Exhibit 10.6 Khosla Ventures Acquisition Co. 2128 Sand Hill Rd Menlo Park, CA 94025 January 22, 2021 Khosla Ventures SPAC Sponsor LLC 2128 Sand Hill Rd Menlo Park, CA 94025 RE: Securities Subscription Agreement Ladies and Gentlemen: This agreement (the ?Agreement?) is entered into on January 22, 2021 by and between Khosla Ventures SPAC Sponsor LLC, a Delaware limited liability company (the ?Subscr |
|
| February 12, 2021 |
First Amended and Restated Certificate of Incorporation. Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF KHOSLA VENTURES ACQUISITION CO. Khosla Ventures Acquisition Co., a corporation under the laws of the State of Delaware, does make, file, and record this Amended and Restated Certificate of Incorporation (the ?Certificate?), and does hereby certify as follows: 1. This corporation was originally incorporated pursuant to the DGCL on Jan |
|
| January 27, 2021 |
Table of Contents This is a confidential draft submission to the U.S. Securities and Exchange Commission on January 27, 2021 and is not being filed under the Securities Act of 1933, as amended. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Khosla Ventures Acquisition Co. (Exact name of |
